These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10406511)

  • 41. Endothelial marker proteins in hyperhomocysteinemia.
    de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
    Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelial dysfunction associated with chronic intravascular coagulation in secondary pulmonary hypertension.
    Lopes AA; Caramurú LH; Maeda NY
    Clin Appl Thromb Hemost; 2002 Oct; 8(4):353-8. PubMed ID: 12516685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Chung WW; Leung CB; Chan K; Lai KN
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
    Navarro JF; Mora C; Macía M; García J
    Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute effects of recombinant human erythropoietin on plasma levels of proendothelin-1 and endothelin-1 in haemodialysis patients.
    Kang DH; Yoon KI; Han DS
    Nephrol Dial Transplant; 1998 Nov; 13(11):2877-83. PubMed ID: 9829494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levels of plasma thrombomodulin are increased in atheromatous arterial disease.
    Seigneur M; Dufourcq P; Conri C; Constans J; Mercié P; Pruvost A; Amiral J; Midy D; Baste JC; Boisseau MR
    Thromb Res; 1993 Sep; 71(6):423-31. PubMed ID: 8134903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma thrombomodulin in orthotopic liver transplantation.
    Boutiere B; Arnoux D; Boffa MC; Samson D; Le Treut YP; Sampol J
    Transplantation; 1994 Dec; 58(12):1352-5. PubMed ID: 7809928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease.
    Doshi SN; Moat SJ; Lewis MJ; McDowell IF; Giddings JC; Goodfellow J
    Int J Cardiol; 2004 Apr; 94(2-3):203-7. PubMed ID: 15093982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells.
    Carlini RG; Dusso AS; Obialo CI; Alvarez UM; Rothstein M
    Kidney Int; 1993 May; 43(5):1010-4. PubMed ID: 8510379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
    Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY
    Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased endothelin: nitric oxide ratio is associated with erythropoietin-induced hypertension in hemodialysis patients.
    Shimada N; Saka S; Sekizuka K; Tanaka A; Takahashi Y; Nakamura T; Ebihara I; Koide H
    Ren Fail; 2003 Jul; 25(4):569-78. PubMed ID: 12911161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity.
    Li Y; Chen H; Tan J; Wang X; Liang H; Sun X
    Eur J Clin Invest; 1998 Dec; 28(12):1050-4. PubMed ID: 9893018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation between soluble markers of endothelial dysfunction in patients with renal failure.
    Jacobson SH; Egberg N; Hylander B; Lundahl J
    Am J Nephrol; 2002; 22(1):42-7. PubMed ID: 11919402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel aspects of erythropoietin response in renal failure patients.
    Sunder-Plassmann G; Hörl WH
    Nephrol Dial Transplant; 2001; 16 Suppl 5():40-4. PubMed ID: 11509683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo).
    Locatelli F; Canaud B; Giacardy F; Martin-Malo A; Baker N; Wilson J
    Nephrol Dial Transplant; 2003 Feb; 18(2):362-9. PubMed ID: 12543893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Markers of endothelial activation in preeclampsia.
    Prochazka M; Procházková J; Lubušký M; Pilka R; Úlehlová J; Michalec I; Polák P; Kacerovský M; Slavik L
    Clin Lab; 2015; 61(1-2):39-46. PubMed ID: 25807636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis.
    Lip GY; Blann AD; Jones AF; Beevers DG
    Am Heart J; 1997 Oct; 134(4):764-71. PubMed ID: 9351746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subcutaneous administration of darbepoetin alfa effectively maintains hemoglobin concentrations at extended dose intervals in peritoneal dialysis patients.
    Fang YW; Chang CH
    Perit Dial Int; 2009; 29(2):199-203. PubMed ID: 19293358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular endothelial markers, von Willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy: comparison of primary renal disease.
    Hirano T; Ookubo K; Kashiwazaki K; Tajima H; Yoshino G; Adachi M
    Clin Chim Acta; 2000 Sep; 299(1-2):65-75. PubMed ID: 10900293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.